NCT05989945View on ClinicalTrials.gov

HIDRAdenitis Suppurativa and HEART Disease

Active, not recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

January 6, 2025

Study Completion Date

August 1, 2033

Conditions
HidradenitisHidradenitis SuppurativaHidradenitis Suppurativa, FamilialLeft Ventricular DysfunctionMyocardial InfarctionMyocardial IschemiaHeart FailureStrokeHeart DiseasesHeart Failure, SystolicHeart Failure, Diastolic
Trial Locations (1)

2900

Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen, Hellerup

All Listed Sponsors
lead

Herlev and Gentofte Hospital

OTHER

NCT05989945 - HIDRAdenitis Suppurativa and HEART Disease | Biotech Hunter | Biotech Hunter